You have 9 free searches left this month | for more free features.

Overall Status

Completed (14)

Recruiting (8)

Active, not recruiting (2)

Not yet recruiting (2)

Available (1)

Sign in for free

Phase

phase 1 (14)

phase 2 (8)

phase 3 (3)

phase 1/phase 2 (1)

Sponsor

Eli Lilly and Company (11)

Loxo Oncology, Inc. (9)

National Cancer Institute (NCI) (2)

AstraZeneca (1)

Helsinki University Central Hospital (1)

M.D. Anderson Cancer Center (1)

Massachusetts General Hospital (1)

Southwest Oncology Group (1)

Collaborator

Eli Lilly and Company (10)

Loxo Oncology, Inc. (10)

Children's Oncology Group (1)

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

drug (27)

other (2)

procedure (2)

Funder Type

Industry (21)

Other (4)

NIH (2)

Study Type

Interventional (26)

Expanded Access (1)

selpercatinib

Showing 26 - 27 of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting

Non-Small Cell Lung Cancer

Osimertinib
+12 more

Duarte, California
+52 more

Jan 19, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting

Advanced Malignant Solid Neoplasm
+44 more

Biopsy
+23 more

Birmingham, Alabama
+166 more

Feb 2, 2023